Back
Results - Announcements
Sales rise 8.76% to Rs 82.23 crore
Jagsonpal Pharmaceuticals standalone net profit rises 22.13% in the June 2026 quarter
29-Jul-2026, 05:53
Net profit of Jagsonpal Pharmaceuticals rose 22.13% to Rs 13.19 crore in the quarter ended June 2026 as against Rs 10.80 crore during the previous quarter ended June 2025. Sales rose 8.76% to Rs 82.23 crore in the quarter ended June 2026 as against Rs 75.61 crore during the previous quarter ended June 2025.
Net profit of Jagsonpal Pharmaceuticals rose 22.13% to Rs 13.19 crore in the quarter ended June 2026 as against Rs 10.80 crore during the previous quarter ended June 2025. Sales rose 8.76% to Rs 82.23 crore in the quarter ended June 2026 as against Rs 75.61 crore during the previous quarter ended June 2025.
| Particulars | Quarter Ended | ||
| Jun. 2026 | Jun. 2025 | % Var. | |
| Sales | 82.23 | 75.61 | 9 |
| OPM % | 20.97 | 18.79 | - |
| PBDT | 19.82 | 16.79 | 18 |
| PBT | 17.68 | 14.44 | 22 |
| NP | 13.19 | 10.80 | 22 |
Powered by Capital Market - Live News